Apparatus

FDA Approves Vabysmo, The First Bispecific Antibody For The Eye!

The US Food and Drug Administration has approved Vabysmo (faricimab-svoa), for the treatment of wet age-related macular degeneration (AMD) and diabetic macular oedema (DME).